What You Should Know About RET-Positive NSCLC: Live from TexasLung25

Episode
275
Soundcloud
Share

In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion live from the Texas Lung Cancer Conference with Dr. Mihaela Aldea about the key information about RET-positive NSCLC, from diagnostic challenges to treatment selection. Join us in this lively discussion.

Guest
Narjust Florez
Narjust Florez

MD

Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Mihaela Aldea
Mihaela Aldea

MD, PhD

Thoracic Oncology and Precision Medicine Group Department of Medical Oncology
Gustave Roussy, Villejuif, France